Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TRLV), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trulieve Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trulieve Cannabis's position in the market.
Trulieve Cannabis (TRLV) will open a new medical cannabis dispensary in Dunwoody, Georgia, with a grand opening on September 10.
The DeKalb County location will host a ribbon cutting at 9:30 a.m. and offer storewide discounts and giveaways. The dispensary at 4675 N. Shallowford Road, Suite 100, operates 10 a.m.–7 p.m. Sunday–Thursday and 10 a.m.–8 p.m. Friday–Saturday, featuring multiple in-house brands in formats such as capsules, flower, tinctures, topicals, troches, and vaporizers.
Trulieve Cannabis (TRLV) will participate in two investor conferences in September 2026. On September 9, 2026, Chief Corporate Affairs and Strategy Officer Christine Hersey will join investor meetings at the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference. On September 29, 2026, Founder and CEO Kim Rivers will participate in investor meetings at the 5th Annual Roth Healthcare Opportunities Conference. Event details, access links, and presentations are available on Trulieve’s investor relations events webpage.
Trulieve (NYSE: TRLV) will ring The Closing Bell® at the New York Stock Exchange at 4:00 p.m. ET on August 18, 2026, to celebrate its June 10, 2026 NYSE listing. According to the company, Trulieve is the first U.S. cannabis company listed on the NYSE.
Founder and CEO Kim Rivers will lead the ceremony with the board and executive team. Trulieve reports operating 207 medical dispensaries, over 5,000 employees, and 3.5 million square feet of cultivation and production capacity across Florida, Georgia, Pennsylvania, and West Virginia, with $109 million in operating cash flow in the first half of 2026 and $325 million in cash at Q2-end.
Trulieve (NYSE: TRLV) completed its previously announced redomicile from British Columbia, Canada to Delaware, United States on August 11, 2026. The move was approved by shareholders on August 5, 2026, received a Final Order from the British Columbia Supreme Court on August 10, 2026, and became effective upon Delaware filings. Trulieve states the U.S. domicile may expand access to U.S. investors and enhance eligibility for broader index inclusion. The company’s subordinate voting shares continue trading on the New York Stock Exchange under ticker “TRLV”.
Trulieve (NYSE: TRLV) reported Q2 2026 revenue of $271 million, down 10% year-over-year and 6% sequentially, with 60% gross margin and GAAP gross profit of $162 million. Retail accounted for 94% of revenue. Adjusted net income was $20 million ($0.11 per diluted share) and adjusted EBITDA was $98 million, a 36% margin.
GAAP net loss attributable to common shareholders was $406 million ($2.10 per share), mainly reflecting a $403.3 million loss on the deconsolidation of Harvest. For the first half of 2026, cash flow from operations totaled $109 million and free cash flow $74 million, with quarter-end cash of $325 million.
The company listed on the New York Stock Exchange under the ticker TRLV, completed deconsolidation of Harvest’s mixed medical and adult-use operations, filed DEA applications for state-licensed medical operations after federal rescheduling to Schedule III, authorized a share repurchase program of up to the lesser of $50 million or 8,495,038 subordinate voting shares, began shipping to licensed independent pharmacies in Georgia, and opened five new Florida dispensaries. Trulieve now operates 207 dispensaries and 3.5 million square feet of cultivation and processing capacity in the U.S.
Trulieve (NYSE: TRLV) announced its planned participation in the Canaccord Genuity 46th Annual Growth Conference on August 12, 2026. Founder and CEO Kim Rivers is scheduled to join a fireside chat and hold investor meetings. Event information and materials are available on Trulieve’s investor events webpage.
Trulieve Cannabis (NYSE: TRLV) announced the opening of a new medical cannabis dispensary in Marco Island, Florida, with a grand opening celebration on Friday, July 24. The location at 615 E Elkcam Circle will serve Collier County patients with walk-in and express pickup options.
The dispensary will operate 9 a.m.–8:45 p.m. Monday–Saturday and 10 a.m.–8 p.m. Sundays, offering Trulieve’s in-house brands such as Co2lors, Cultivar Collection, Modern Flower, Momenta, Roll One, and Sweet Talk, plus exclusive Florida partner brands like Alien Labs, Connected Cannabis, Khalifa Kush, Seed Junky, and others. According to Trulieve, Florida patients also have access to home delivery, online ordering, in-store pickup, a 20% veteran discount with military ID, and a 60% new customer discount for first-time guests at any Florida location.
Trulieve Cannabis Corp (NYSE: TRLV) will hold a conference call on Friday, August 7, 2026 at 8:30 AM Eastern Time to discuss its second quarter 2026 financial and operating results. Chairman, Founder and CEO Kim Rivers and CFO Jan Reese will host the call, which will be accessible by phone and live audio webcast, with an archived replay available online.
Trulieve (NYSE: TRLV) announced it has been named to TIME's America's Best Companies 2026 list, which recognizes the top 1,000 U.S. companies. The ranking, compiled by TIME and Statista, evaluates firms on employee satisfaction, financial performance, and sustainability transparency.
More than 7,200 companies met eligibility criteria, and Trulieve is one of only two cannabis companies included. The assessment used about 217,000 employee surveys, multi-year financial data for companies with at least $100 million in revenue, and analysis of environmental, social, and governance disclosures.
Trulieve (NYSE: TRLV) marked Georgia’s expanded medical cannabis program with a ceremonial first sale at its Marietta dispensary. New law SB 220 allows flower and vaporization products for patients 21+ and broadens qualifying conditions. Trulieve is also supplying products to over a dozen licensed independent pharmacies statewide.